In vitro activity of HSR-903, a new quinolone.
The in vitro activity of the new fluoroquinolone HSR-903 was compared with those of ciprofloxacin, lomefloxacin, sparfloxacin, and levofloxacin. HSR-903 inhibited 90% of methicillin-susceptible and -resistant Staphylococcus aureus (MRSA) clinical isolates at 0.78 and 1.56 microg/ml, respectively, an...
Na minha lista:
| Publicado no: | Antimicrob Agents Chemother |
|---|---|
| Principais autores: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
American Society for Microbiology (ASM)
1997
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC163909/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/9174193/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.41.6.1326 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|